GILD
GILEAD SCIENCES, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$150.11
−0.52%0
Insider buys (3m)
26
Insider sells (3m)
-$15.4M
Net value (3m)
+20.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 16, 2026 | Mercier Johanna · officer: Chief Comm & Corp Aff Officer | Sale | 1,600 | $144 |
| Sep 16, 2026 | Dickinson Andrew D · officer: Chief Financial Officer | Sale | 3,000 | $145 |
| Sep 16, 2026 | Mercier Johanna · officer: Chief Comm & Corp Aff Officer | Sale | 800 | $144 |
| Sep 16, 2026 | Mercier Johanna · officer: Chief Comm & Corp Aff Officer | Sale | 600 | $145 |
| Sep 11, 2026 | Mercier Johanna · officer: Chief Comm & Corp Aff Officer | F-InKind | 1,347 | $145 |
| Sep 11, 2026 | Cain Wettan Keeley M · officer: EVP Gen Counsel, Legal & Comp | M-Exempt | 590 | $0.00 |
| Sep 11, 2026 | O'Day Daniel Patrick · director, officer: Chairman & CEO | M-Exempt | 8,780 | $0.00 |
| Sep 11, 2026 | Mercier Johanna · officer: Chief Comm & Corp Aff Officer | M-Exempt | 2,797 | $0.00 |
| Sep 11, 2026 | Dickinson Andrew D · officer: Chief Financial Officer | M-Exempt | 2,797 | $0.00 |
| Sep 11, 2026 | O'Day Daniel Patrick · director, officer: Chairman & CEO | F-InKind | 4,230 | $145 |
| Sep 11, 2026 | Cain Wettan Keeley M · officer: EVP Gen Counsel, Legal & Comp | F-InKind | 285 | $145 |
| Sep 11, 2026 | Dickinson Andrew D · officer: Chief Financial Officer | F-InKind | 1,347 | $145 |
| Sep 11, 2026 | Berger Dietmar · officer: Chief Medical Officer | M-Exempt | 533 | $0.00 |
| Sep 11, 2026 | Berger Dietmar · officer: Chief Medical Officer | F-InKind | 263 | $145 |
| Sep 2, 2026 | O'Day Daniel Patrick · director, officer: Chairman & CEO | Sale | 1,600 | $148 |
| Sep 2, 2026 | O'Day Daniel Patrick · director, officer: Chairman & CEO | Sale | 5,408 | $149 |
| Sep 2, 2026 | O'Day Daniel Patrick · director, officer: Chairman & CEO | Sale | 7,992 | $148 |
| Aug 27, 2026 | WELTERS ANTHONY · director | Sale | 4,600 | $149 |
| Aug 27, 2026 | WELTERS ANTHONY · director | M-Exempt | 7,718 | $61 |
| Aug 27, 2026 | WELTERS ANTHONY · director | Sale | 3,118 | $148 |
| Aug 27, 2026 | WELTERS ANTHONY · director | Sale | 6,880 | $149 |
| Aug 27, 2026 | WELTERS ANTHONY · director | M-Exempt | 10,282 | $61 |
| Aug 27, 2026 | WELTERS ANTHONY · director | Sale | 3,402 | $148 |
| Aug 21, 2026 | Bluestone Jeffrey · director | M-Exempt | 4,665 | $67 |
| Aug 21, 2026 | Bluestone Jeffrey · director | Sale | 1,816 | $145 |
| Aug 21, 2026 | Bluestone Jeffrey · director | M-Exempt | 1,816 | $67 |
| Aug 21, 2026 | Bluestone Jeffrey · director | Sale | 335 | $146 |
| Aug 21, 2026 | Bluestone Jeffrey · director | M-Exempt | 1,658 | $67 |
| Aug 21, 2026 | Bluestone Jeffrey · director | M-Exempt | 1,165 | $67 |
| Aug 21, 2026 | Bluestone Jeffrey · director | Sale | 26 | $146 |
Institutional positioning
13F filings over the trailing two quarters
New 398Increased 1802Reduced 1775Sold out 171
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 121,844,108 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 119,010,973 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 81,091,734 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 80,654,776 | May 15, 2026 |
| FMR LLC | Increased | 71,906,290 | May 15, 2026 |
| FMR LLC | Reduced | 66,870,816 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 61,216,552 | Aug 7, 2026 |
| STATE STREET CORP | Reduced | 59,858,585 | May 15, 2026 |
| CAPITAL WORLD INVESTORS | Reduced | 41,283,933 | May 13, 2026 |
| Capital World Investors | Reduced | 40,988,975 | Aug 12, 2026 |
| Invesco Ltd. | Increased | 39,819,151 | Aug 14, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 35,316,168 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 35,129,465 | May 8, 2026 |
| JPMORGAN CHASE & CO | Increased | 33,992,410 | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 30,065,642 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 16, 2026